Will STZ Stock Benefit from Its Fiscal 1Q18 Results?
Constellation Brands stock has risen 20.4% to $184.57 as of June 23, 2017. The company has outperformed other major nonalcoholic beverage companies’ stocks on a year-to-date basis.
With the competition intensifying in the beer space, it remains to be seen whether Constellation Brands’ beer portfolio will continue to enjoy strong demand.
Constellation Brands (STZ) delivered impressive margin growth last year. The company’s gross margin was 48.1% in fiscal 2017, a rise of 44.9% compared to fiscal 2016.
Constellation Brands (STZ) has delivered strong sales growth over the past few quarters backed by its strategic acquisitions and the strength of its imported beer portfolio.
Constellation Brands (STZ) is scheduled to announce its fiscal 1Q18 results on June 29, 2017. Its fiscal 1Q18 ended on May 31, 2017.
In June 2017, 16 of the 29 analysts covering JPMorgan Chase (JPM) rated the stock as a “buy” or “strong buy” as compared to 17 analysts in March 2017 and 15 analysts in April 2017.
In 2Q17, JPM is expected to rise 3.9% on a year-over-year basis, reflecting lower growth due to a marginal rise in broad markets (SPX-INDEX) (SPY), lower trading activity, and lower credit offtake.
JPMorgan Chase’s (JPM) commercial banking is expected to see improved margins in 2Q17 on higher rates, deposit growth, and marginally higher loan offtake.
In recent quarters, JPMorgan Chase (JPM) has returned 70%–75% of its net profits to shareholders in the form of dividends and repurchases.
JPMorgan Chase’s (JPM) Consumer and Community Banking division manages revenues from consumer and business banking, its credit card business, and mortgage banking.
JPMorgan Chase’s (JPM) asset management business has seen strong growth over the past few quarters on the back of rising valuations of equity and debt holdings.
JPMorgan Chase (JPM) has garnered strong growth in recent quarters on corporate advisory, equity and debt underwriting, and higher trading activity across asset classes.
JPMorgan Chase (JPM) is expected to post earnings per share (or EPS) of $1.61 in 2Q17 and $6.66 for the full year.
Walgreens Boots Alliance’s (WBA) proposed acquisition of Rite Aid (RAD) continues to await FTC (Federal Trade Commission) approval 20 months after the deal’s announcement.
Walgreens Boots Alliance (WBA) will be reporting its fiscal 3Q17 results on June 29, 2017. The company is expected to report a 0.8% YoY (year-over-year) rise in its total sales.
Walgreens Boots Alliance’s (WBA) fiscal 3Q17 earnings per share (or EPS) are expected to rise 10.2% YoY (year-over-year) to $1.30.
Walgreens Boots Alliance is scheduled to release its fiscal 3Q17 results on June 29, 2017. The pharmacy giant is expected to report a 10.2% year-over-year rise in its earnings per share.
As of June 21, analysts were expecting Darden’s stock price to reach $86.86 in the next 12-months, which implies a fall of 1.6% from its current level.
Analysts are expecting Darden Restaurants (DRI) to post EPS of $1.15 in fiscal 4Q17, which would be a growth of 5.3% over its $1.09 in fiscal 4Q16.
On June 21, 2017, Darden was trading at a PE multiple of 20x, as compared to 17.8x before the announcement of its fiscal 3Q17 earnings.